Skip to content

Type 2 Diabetes In Young People Set To Swell By Nearly 700% Over The Next Few Decades, Study Finds

  • by

According to a new study, diabetes rates have also risen in recent years, along with obesity rates, particularly among children.

Over the following four decades, diabetes among young people is predicted to rise by up to 700%, according to a study published in Diabetes Care.

The Centers for Disease Control and Prevention released a statement on the subject last week in response to that startling statistic, emphasising that the new findings “should serve as a wake-up call for all of us.”

Type 2 Diabetes In Young People Set To Swell By Nearly 700% Over The Next Few Decades, Study Finds

The COVID-19 pandemic, according to Debra Houry, the acting principal deputy director of the CDC, “understood how critically crucial it is to address chronic diseases like diabetes.” This study emphasises the value of ongoing efforts to manage and prevent chronic diseases, not just for the benefit of the current population but also for future generations.

The SEARCH for Diabetes in Youth research, which was supported by the CDC, provided data between 2002 and 2017. If the current rising trends continue, it was predicted that the number of young individuals under the age of 20 with type 2 diabetes might increase from 28,000 in 2017 to 220,000 in 2060.

The researchers also discovered that type 1 diabetes will increase by 65%, compared to a 673% increase in type 2 diabetes, assuming that recent rising patterns continue. By 2060, there may be more than 520,000 adolescents under the age of 20 who have diabetes in total, up from 213,000 in 2017.

The study found that young people who are Black, Hispanic/Latino, Asian, Pacific Islander, and Native American were more likely to have type 2 diabetes than other young people.

According to Christopher Holliday, director of the CDC’s division of diabetes translation, “These numbers are disturbing.” The surprising forecasts of type 2 diabetes rises in this study demonstrate why it is so important to promote health equity and lessen the pervasive gaps that already have a negative impact on people’s health.

According to CDC data, obesity rates have also been rising consistently, from 30.5% in the years 1999 to 2000 to 41.9% in the years 2017 to 2020.

The prevalence of obesity among young people aged two to 19 from 2017 to 2020 was close to 20%. With a higher rate of 26.2% for Latino/Hispanic children and 24.8% for non-Hispanic Black children, respectively,

The newest revelation comes at a time when several diabetes medications, including Mounjaro and Trulicity from Eli Lilly and Ozempic from Novo Nordisk, are in low supply due to the rising demand for diabetes and obesity therapies.

The Food and Drug Administration has currently licenced Ozempic to treat type 2 diabetes; however, it has also been prescribed off-label for weight loss, which has made the scarcity worse. Even though these novel medications are only approved for the treatment of diabetes, there has been an increasing buzz about their potential as medications for obesity or weight loss, particularly among celebrities and TikTokers.

As rates of both diabetes and obesity rise, it is anticipated that the “diabesity” epidemic will continue to gain attention in the pharmaceutical industry in the future years.

Leave a Reply

Your email address will not be published. Required fields are marked *